DK0571474T3 - Orthomolekylær fremgangsmåde til behandling af seglcellesygdom - Google Patents
Orthomolekylær fremgangsmåde til behandling af seglcellesygdomInfo
- Publication number
- DK0571474T3 DK0571474T3 DK92904928T DK92904928T DK0571474T3 DK 0571474 T3 DK0571474 T3 DK 0571474T3 DK 92904928 T DK92904928 T DK 92904928T DK 92904928 T DK92904928 T DK 92904928T DK 0571474 T3 DK0571474 T3 DK 0571474T3
- Authority
- DK
- Denmark
- Prior art keywords
- orthomolecular
- treatment
- sickle cell
- cell disease
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/652,773 US5108754A (en) | 1991-02-08 | 1991-02-08 | Orthomolecular method of treating sickle cell disease |
PCT/US1992/000450 WO1992013522A1 (en) | 1991-02-08 | 1992-01-31 | Orthomolecular method of treating sickle cell disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0571474T3 true DK0571474T3 (da) | 1999-08-30 |
Family
ID=24618098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92904928T DK0571474T3 (da) | 1991-02-08 | 1992-01-31 | Orthomolekylær fremgangsmåde til behandling af seglcellesygdom |
Country Status (15)
Country | Link |
---|---|
US (1) | US5108754A (da) |
EP (1) | EP0571474B1 (da) |
JP (1) | JPH06507382A (da) |
KR (1) | KR100221118B1 (da) |
AP (1) | AP275A (da) |
AT (1) | ATE175204T1 (da) |
AU (1) | AU662124B2 (da) |
BR (1) | BR9205609A (da) |
CA (1) | CA2103580C (da) |
DE (1) | DE69228054T2 (da) |
DK (1) | DK0571474T3 (da) |
ES (1) | ES2125887T3 (da) |
GR (1) | GR3029742T3 (da) |
IL (1) | IL100663A (da) |
WO (1) | WO1992013522A1 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
HUT72422A (en) * | 1994-04-20 | 1996-04-29 | Beres Export Import Rt | Aquous concentrate and process for its preparation |
US5626884A (en) * | 1995-08-18 | 1997-05-06 | Lockett; Curtis G. | Treatment of sickle cell disease |
US5693671A (en) * | 1996-05-01 | 1997-12-02 | Harbor-Ucla Research And Education Institute | L-glutamine therapy for sickle cell diseases and thalassemia |
US20080153761A1 (en) * | 1998-04-08 | 2008-06-26 | Theoharides Theoharis C | Compositions for protection against superficial vasodilator flush syndrome, and methods of use |
DE10062401A1 (de) * | 2000-12-14 | 2002-06-20 | Beiersdorf Ag | Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA |
KR20020088498A (ko) * | 2001-05-17 | 2002-11-29 | (주)미토콘 | 에스-아데노실메티오닌을 유효성분으로 함유하는 인슐린저항증 개선용 조성물 |
DE10243234A1 (de) * | 2002-09-17 | 2004-03-25 | Phenion Gmbh & Co. Kg | Tocopherylester |
WO2005007173A1 (en) * | 2003-07-09 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health | Use of nitrite salts for the treatment of cardiovascular conditions |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
US7250445B1 (en) * | 2005-01-14 | 2007-07-31 | Ehrenpreis Eli D | Anti-oxidant suppository for treating radiation proctopathy and other anorectal disorders |
EP2237788A4 (en) * | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
US8840950B2 (en) | 2010-05-26 | 2014-09-23 | Jacqueline M. Hibbert | Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore |
CN107075441A (zh) * | 2014-07-30 | 2017-08-18 | 卡斯西部储备大学 | 诊断血红蛋白病症和监测血细胞的生物芯片 |
EP3204004A4 (en) * | 2014-10-08 | 2018-05-30 | Epigenetics Pharma LLC | Vitamin e-nucleoside prodrugs |
WO2016196281A1 (en) * | 2015-06-01 | 2016-12-08 | Nanometics Llc | Mtap inhibitors for the treatment of sickle cemtap disease |
US10349589B2 (en) | 2016-09-08 | 2019-07-16 | Hemex Health, Inc. | Diagnostics systems and methods |
EP3510396B1 (en) | 2016-09-08 | 2021-12-08 | Hemex Health, Inc. | Diagnostics system |
KR20190092778A (ko) | 2018-01-31 | 2019-08-08 | 양원용 | 태양광을 이용한 기능성 전동식 농약분무기 |
US11740203B2 (en) | 2019-06-25 | 2023-08-29 | Hemex Health, Inc. | Diagnostics systems and methods |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL57609A (en) * | 1979-06-21 | 1983-05-15 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids |
US4612194A (en) * | 1984-02-15 | 1986-09-16 | Roshdy Ismail | Anti-rheumatic agents and their use |
GB8606913D0 (en) * | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
-
1991
- 1991-02-08 US US07/652,773 patent/US5108754A/en not_active Expired - Fee Related
-
1992
- 1992-01-15 IL IL10066392A patent/IL100663A/en not_active IP Right Cessation
- 1992-01-27 AP APAP/P/1992/000358A patent/AP275A/en active
- 1992-01-31 JP JP4505377A patent/JPH06507382A/ja active Pending
- 1992-01-31 DE DE69228054T patent/DE69228054T2/de not_active Expired - Fee Related
- 1992-01-31 WO PCT/US1992/000450 patent/WO1992013522A1/en active IP Right Grant
- 1992-01-31 DK DK92904928T patent/DK0571474T3/da active
- 1992-01-31 AT AT92904928T patent/ATE175204T1/de not_active IP Right Cessation
- 1992-01-31 BR BR9205609A patent/BR9205609A/pt not_active Application Discontinuation
- 1992-01-31 EP EP92904928A patent/EP0571474B1/en not_active Expired - Lifetime
- 1992-01-31 KR KR1019930702363A patent/KR100221118B1/ko not_active IP Right Cessation
- 1992-01-31 ES ES92904928T patent/ES2125887T3/es not_active Expired - Lifetime
- 1992-01-31 CA CA002103580A patent/CA2103580C/en not_active Expired - Fee Related
- 1992-01-31 AU AU12505/92A patent/AU662124B2/en not_active Ceased
-
1999
- 1999-03-19 GR GR990400827T patent/GR3029742T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU1250592A (en) | 1992-09-07 |
CA2103580C (en) | 2002-11-26 |
AP9200358A0 (en) | 1992-04-30 |
JPH06507382A (ja) | 1994-08-25 |
US5108754A (en) | 1992-04-28 |
AP275A (en) | 1993-07-18 |
EP0571474A1 (en) | 1993-12-01 |
AU662124B2 (en) | 1995-08-24 |
KR100221118B1 (ko) | 1999-09-15 |
ES2125887T3 (es) | 1999-03-16 |
CA2103580A1 (en) | 1992-08-09 |
EP0571474A4 (da) | 1994-02-09 |
IL100663A0 (en) | 1992-09-06 |
IL100663A (en) | 1995-10-31 |
WO1992013522A1 (en) | 1992-08-20 |
EP0571474B1 (en) | 1998-12-30 |
ATE175204T1 (de) | 1999-01-15 |
BR9205609A (pt) | 1994-07-26 |
DE69228054D1 (de) | 1999-02-11 |
DE69228054T2 (de) | 1999-08-05 |
GR3029742T3 (en) | 1999-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0571474T3 (da) | Orthomolekylær fremgangsmåde til behandling af seglcellesygdom | |
DK186688D0 (da) | Fremgangsmaade til dyrkning af leukocytter | |
DK36491A (da) | Praeparat til behandling af erektiv dysfunktion | |
FI890130A (fi) | Anordning vid framstaellning av ett intravenoest filter foer implantation. | |
DK198588D0 (da) | Fremgangsmaade til behandling af spildevand | |
DK176487D0 (da) | Middel til behandling af inflammationer i oejet | |
NO912151D0 (no) | Essensiell-fettsyre-behandling. | |
FI905124A0 (fi) | Menetelmä pyrimidiinien valmistamiseksi | |
DK439682A (da) | Apparat til behandling af afgroede | |
DK447489A (da) | Metode til stabilisering af blod | |
FI912335A0 (fi) | Foerfarande foer framstaellning av rikligt med fastaemnen innehaollande uppslamningar. | |
DK162806C (da) | Fremgangsmaade til bedoevelse af lungeaandende slagtedyr | |
DK524489A (da) | Fremgangsmaade til fremstilling af biologisk aktive forbindelser, specielt enzymer | |
DK101197A (da) | Medikament til behandling af thrombocytopenia | |
DK39789D0 (da) | Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre | |
DK281590D0 (da) | Fremgangsmaade til regenereringsbehandling af overvejende lerbundet stoeberigammelsand | |
DK0458855T3 (da) | Farmaceutisk præparat til behandling af tonsillitis | |
DK0519512T3 (da) | Mikrobiologisk fremgangsmåde til fremstilling af 5-hydroxypyrazincarboxylsyre | |
DK500589D0 (da) | Farmaceutisk praeparat til behandling af lungeobstruktioner | |
DK72288D0 (da) | Farmaceutisk praeparat til behandling af ulcerativ tyktarmssygdom | |
DK0546906T3 (da) | Ny fremgangsmåde til fremstilling af 4-amino-5-hexensyre | |
DK0553792T3 (da) | Fremgangsmåde til fremstilling af dinatriumsalt,hemiheptahydratet af cefriaxon | |
NO910556L (no) | Fremgangsmaate for fremstilling av 7-amino-3-metoksymetyl-cef-3-em-4-karboksylsyre. | |
NO904496L (no) | Fremgangsmaate for fremstilling av optisk aktive tiazetokinolin-3-karboksylsyreforbindelser. | |
ATE137592T1 (de) | Vorblitz-me methode |